Почетна › Атеросклероза › Пенсилванија
Kliničke studije za Атеросклероза u državi Пенсилванија
9 studija za Атеросклероза traži učesnike na lokacijama u državi Пенсилванија.
Gradovi u državi Пенсилванија
Zvanični tekst studije (na engleskom)
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
- Capital Area Research, LLC - Camp Hill, Camp Hill
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 5. 11. 2026. · NCT07521007A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
- Heart and Vascular Research at WellSpan Health, York
Тражи се учесникФаза 3
Узраст од 45 до 80 · Оба пола · Ажурирано 4. 11. 2026. · NCT07613294A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Suburban Research Associates, West Chester
- Cardiology Consultants of Philadelphia Yardley, Yardley
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07783802A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
- Preferred Primary Care Physicians, Inc, Pittsburgh
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07448038How Animal and Plant Protein Shakes Change the Body's Nutrient and Health Responses
- UPMC Montefiore - Clinical and Translational Research Center (CTRC), Pittsburgh
Тражи се учесникЗдраве особе су добродошле
Узраст од 18 до 65 · Оба пола · Ажурирано 6. 10. 2026. · NCT07121010Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Lehigh Valley Health Network, Allentown
- Capital Area Research, LLC, Camp Hill
- Altoona Center For Clinical Research, Duncansville
- и још 5
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 24. 9. 2026. · NCT07157774Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Northeast Clinical Research Center, LLC, Bethlehem
- Clinical Renal Associates, LTD, Exton
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 21. 9. 2026. · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Camp Hill
- Research Site, Horsham
- Research Site, Philadelphia
- и још 5
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 24. 8. 2026. · NCT07000357MetfOrmin BenefIts Lower Extremities With Intermittent Claudication
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh
Тражи се учесникФаза 3
Узраст од 35 до 89 · Оба пола · Ажурирано 21. 4. 2026. · NCT05132439Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.